Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Maresin-1 Level Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis Patients

NCT03364920 is registered in ClinicalTrials.gov with Weiqin Li as lead sponsor.

NCT NCT03364920
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03364920 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Maresin-1 Level Predicts the Disease Severity and Clinical Outcomes of Severe Acute Pancreatitis Patients
Lead sponsor
Weiqin Li
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
January 1, 2020
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, acute